Name: OS Therapies Incorporated (OSTX) Financial Statements
Creator: FinSpry

OS Therapies Incorporated Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

OS Therapies Incorporated income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	1.16	4.25
Gross Profit	0.00	0.00	0.00	-1.16	-4.25
Operating Expenses
Research & Development	2.84	3.22	3.29	2.17	0.60
Selling, General & Administrative	3.97	1.13	1.15	1.50	0.80
Operating Expenses	6.81	4.34	4.45	3.68	1.40
Operating Income	-6.81	-4.34	-4.45	-4.84	-5.65
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.06
Interest Expense	2.05	3.45	1.81	-2.58	-0.46
Other Income/Expense	-2.07	0.00	0.00	0.00	0.02
Income
Income Before Tax	-8.88	-7.79	-6.25	-7.42	-6.03
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-8.88	-7.79	-6.25	-7.42	-6.03
Net Income - Continuous Operations	-8.88	-7.79	-6.25	-7.42	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-6.83	-4.34	-4.45	-4.84	-5.65
EBIT	-6.81	-4.34	-4.45	-4.84	-5.65
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-	-	-1.00	-1.00
Diluted EPS	-1.00	-	-	-1.00	-1.00
Basic Shares Outstanding	20.87	20.60	20.05	9.98	8.42
Diluted Shares Outstanding	20.87	20.60	20.05	9.98	8.42